NDC 66689-020-01 - Megestrol Acetate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 66689-020
- Requested NDC
- 66689-020-01
- Package NDCs from labels
- 66689-020-01, 66689-020-50, 66689-020-99
- Manufacturer
- VistaPharm, LLC
- Effective date
- 2024-07-11
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Megestrol Acetate - VistaPharm, LLC | VistaPharm, LLC | 2024-07-11 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-02-13 | Indexing - Billing Unit |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 66689-020-50 | 2024-01-30 | C162847 | 48780-1 | 1030e365-55f2-111a-e063-dadaa90a10e2 | MEGESTROL ACETATE ORAL SUSPENSION, USP Rx Only |
| 66689-020-99 | 2024-01-30 | C162847 | 48780-1 | 1030e365-55f2-111a-e063-dadaa90a10e2 | MEGESTROL ACETATE ORAL SUSPENSION, USP Rx Only |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 66689-020-01 | ML - Milliliter | 66689-020 | ebf9bcec-2fd9-4b8b-a2bc-d632d9153bcc | 1 | 2013-02-13 |
| 66689-020-50 | ML - Milliliter | 66689-020 | 1231295f-9960-4ee0-b3df-922d16d5c7fc | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Megestrol Acetate | ACTIVE INGREDIENT | TJ2M0FR8ES | MEGESTROL ACETATE SUSPENSION [VISTAPHARM, INC.] | 2 | |
| Megestrol | ACTIVE MOIETY | EA6LD1M70M | MEGESTROL ACETATE SUSPENSION [VISTAPHARM, INC.] | 2 | |
| Citric Acid Monohydrate | INACTIVE INGREDIENT | 2968PHW8QP | MEGESTROL ACETATE SUSPENSION [VISTAPHARM, INC.] | 2 | |
| Docusate Sodium | INACTIVE INGREDIENT | F05Q2T2JA0 | MEGESTROL ACETATE SUSPENSION [VISTAPHARM, INC.] | 2 | |
| Glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | MEGESTROL ACETATE SUSPENSION [VISTAPHARM, INC.] | 2 | |
| Sodium Benzoate | INACTIVE INGREDIENT | OJ245FE5EU | MEGESTROL ACETATE SUSPENSION [VISTAPHARM, INC.] | 2 | |
| Sucrose | INACTIVE INGREDIENT | C151H8M554 | MEGESTROL ACETATE SUSPENSION [VISTAPHARM, INC.] | 2 | |
| Trisodium Citrate Dihydrate | INACTIVE INGREDIENT | B22547B95K | MEGESTROL ACETATE SUSPENSION [VISTAPHARM, INC.] | 2 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | MEGESTROL ACETATE SUSPENSION [VISTAPHARM, INC.] | 2 | |
| Xanthan Gum | INACTIVE INGREDIENT | TTV12P4NEE | MEGESTROL ACETATE SUSPENSION [VISTAPHARM, INC.] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Stool Softener | DOCUSATE SODIUM | Amerisource Bergen | 4caf0bcb-c1bf-0ae7-e063-6294a90a344b | 2026-03-10 | Warnings | F05Q2T2JA0 |
| Stool Softener Laxative | DOCUSATE SODIUM | Walgreens | 92df761b-da68-4ce9-b02a-a5a74fd6620e | 2026-03-10 | Warnings | F05Q2T2JA0 |
| Senna S | DOCUSATE SODIUM, SENNOSIDES | Walgreens | b03e1500-0a4f-4e3d-a897-d7781fd5f791 | 2026-03-09 | Warnings | F05Q2T2JA0 |
| Fleet | GLYCERIN | C.B. Fleet Company, Inc. | 31778652-e60e-4098-8e90-3e4f56b5800c | 2026-03-06 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | Beijing Jingfeng Pharmaceutical (Shandong) Co., Ltd | 4c6094b7-c1ef-26a3-e063-6394a90af4cc | 2026-03-06 | Warnings | PDC6A3C0OX |
| 2-Pack Facial Serum | 2-PACK FACIAL SERUM | Guangzhou Ariel Biotech Co., Ltd. | 27c7f645-cfb3-6db1-e063-6394a90a42ff | 2026-03-06 | Warnings | 059QF0KO0R |
| Artificial Tears | GLYCERIN | Preferred Pharmaceuticals Inc. | dd646c72-8f47-43c6-a734-db0dcc8cd4d1 | 2026-03-06 | Warnings | PDC6A3C0OX |
| Stool Softener plus Stimulant Laxative | DOCUSATE SODIUM 50 MG AND SENNOSIDES 8.6 MG | CARDINAL HEALTH, 110 DBA LEADER | 3fd9ba76-42f8-4ebe-b1bc-f81f08e702ce | 2026-03-06 | Warnings | F05Q2T2JA0 |
| Docusate Sodium | DOCUSATE SODIUM 100MG | Pharbest Pharmaceuticals, Inc. | 025e03e0-e273-47ed-87f7-98e388abe047 | 2026-03-05 | Warnings | F05Q2T2JA0 |
| Dry Eye Relief Sterile Lubricant Eye Drops | GLYCERIN | Similasan Corporation | 4c4cce1c-392e-354d-e063-6294a90a0ca3 | 2026-03-05 | Warnings | PDC6A3C0OX |
| Sore Throat | PHENOL GLYCERIN | CVS PHARMACY, INC | 9683bcfb-2f7e-48a4-aa79-500ee8df099a | 2026-03-02 | Warnings | PDC6A3C0OX |
| Refresh Optive Mega-3 PF | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80 | Allergan, Inc. | 326cb5d6-c784-404f-9a13-6d69262dda6e | 2026-03-01 | Warnings | PDC6A3C0OX |
| Dermatool Hemorrhoidal | GLYCERIN, LIDOCAINE, PETROLATUM, PHENYLEPHRINE HCL | Papalo Group LLC | 4bc06f41-7733-ebd0-e063-6294a90af7a8 | 2026-02-26 | Warnings | PDC6A3C0OX |
| DOCUSATE SODIUM | DOCUSATE SODIUM | PD-Rx Pharmaceuticals, Inc. | 5d300ea7-78eb-4e19-8333-1e42c73c4c54 | 2026-02-26 | Warnings | F05Q2T2JA0 |
| Tricitrates | TRICITRATES | Chartwell Governmental & Specialty RX, LLC. | c4ff0407-3930-4c48-afd4-d2cb3e1b18f4 | 2026-02-25 | Warnings, Adverse reactions | 2968PHW8QP |
| Potassium Citrate and Citric Acid | POTASSIUM CITRATE AND CITRIC ACID | Chartwell Governmental & Specialty RX, LLC. | fd57a176-7faf-4053-b348-6ba5f192f05a | 2026-02-25 | Warnings, Adverse reactions | 2968PHW8QP |
| SENNA-S | DOCUSATE SODIUM AND SENNOSIDES | Advanced Rx LLC | d148be81-79b4-41f7-b8d8-a0e85b661592 | 2026-02-18 | Warnings | F05Q2T2JA0 |
| Stool Softener Laxative | DOCUSATE SODIUM | The Kroger Co. | e1a68bd9-d31a-46a6-8c08-7ad8197b6e0b | 2026-02-13 | Warnings | F05Q2T2JA0 |
| WowDay Hemorrhoid and Fissure Cream | HEMORRHOID AND FISSURE CREAM | WowDay LLC | 47ba86ad-240a-e733-e063-6394a90a24e3 | 2026-02-12 | Warnings | PDC6A3C0OX |
| Viva Hydration Boost | GLYCERIN | Nomax Inc | 174193b2-65eb-b5fd-e063-6394a90a9cd0 | 2026-02-10 | Warnings | PDC6A3C0OX |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.